Company: HCWB
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001193125-25-283238
Chunk: 11

Company: HCW Biologics Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 11
---
HCW Biologics Inc. 

Condensed Balance Sheets 

     December 31,

     September 30,

     2024

     2025

     Unaudited

     ASSETS

     Current assets:

     Cash and cash equivalents
      
     $
     4,674,572

     $
     1,096,909

     Accounts receivable, net

     582,201

     30,667

     Prepaid expenses

     328,181

     210,661

     Other current assets

     113,528

     250,340

     Total current assets

     5,698,482

     1,588,577

     Investments

     1,599,751

     1,326,329

     Property, plant and equipment, net

     22,909,869

     22,502,158

     Other assets

     28,476

     28,476

     Total assets
      
     $
     30,236,578

     $
     25,445,540

     LIABILITIES AND STOCKHOLDERS’ DEFICIT

     Liabilities

     Current liabilities:

     Accounts payable
      
     $
     22,332,261

     $
     18,968,173

     Accrued liabilities and other current liabilities

     981,940

     1,084,602

     Short-term debt, net

     6,314,684

     6,807,431

     Total current liabilities

     29,628,885

     26,860,206

     Debt, net

     7,377,865

     —

     Contingent liability - related party

     —

     692,531

     Total liabilities

     37,006,750

     27,552,737

     Commitments and contingencies (Note 11)

     Stockholders’ deficit:

     Common stock:

     Common, $0.0001 par value; 250,000,000 shares authorized   and 1,113,532 shares issued at December 31, 2024; 250,000,000 shares    authorized and 2,621,607 shares issued at September 30, 2025

     111

     262

     Additional paid-in capital